New way for states to cover pricey gene therapies will start with sickle cell disease
Briefly

The new sickle cell treatments have brought hope to those with the debilitating blood disorder, which is hereditary and disproportionately affects Black people.
The federal government said it will negotiate an outcomes-based agreement with the companies, meaning the prices for treatments will be tied to whether the therapy improves health outcomes.
Read at www.bostonherald.com
[
add
]
[
|
|
]